Literature DB >> 2827647

Effects of a platelet activating factor antagonist (BN 52021) on free fatty acids, diacylglycerols, polyphosphoinositides and blood flow in the gerbil brain: inhibition of ischemia-reperfusion induced cerebral injury.

T Panetta1, V L Marcheselli, P Braquet, B Spinnewyn, N G Bazan.   

Abstract

The effects of a platelet activating factor antagonist (BN 52021) on cerebral ischemia-reperfusion was studied in the gerbil. Following ten minutes of bilateral carotid artery ligation, gerbils were reperfused and injected intraperitoneally with either BN 52021 or vehicle-dimethylsulfoxide. Cerebral blood flow and systemic arterial pressure were monitored until 90 minutes of reperfusion. Free fatty acids, diacylglycerols and polyphosphoinositides were then analyzed in forebrains and midbrains. BN 52021 inhibited the maturation of ischemic injury. Cerebral blood flow increased following 60 to 90 minutes of reperfusion. Free fatty acid levels were reduced likely by inhibition of phospholipase A. Phospholipase activity may likely be decreased since there was a tendency to increase phosphatidylinositol-4',5'-bisphosphate and diacylglycerols in BN 52021-treated animals.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2827647     DOI: 10.1016/0006-291x(87)90407-4

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

Review 1.  Excitable membranes, lipid messengers, and immediate-early genes. Alteration of signal transduction in neuromodulation and neurotrauma.

Authors:  J P Doucet; N G Bazan
Journal:  Mol Neurobiol       Date:  1992       Impact factor: 5.590

Review 2.  Fos-jun and the primary genomic response in the nervous system. Possible physiological role and pathophysiological significance.

Authors:  J P Doucet; S P Squinto; N G Bazan
Journal:  Mol Neurobiol       Date:  1990 Spring-Summer       Impact factor: 5.590

Review 3.  PAF. A review of its effects, antagonists and possible future clinical implications (Part II).

Authors:  M Koltai; D Hosford; P Guinot; A Esanu; P Braquet
Journal:  Drugs       Date:  1991-08       Impact factor: 9.546

Review 4.  Pharmacologic neuroprotection: the search continues.

Authors:  Hilary P Grocott
Journal:  J Extra Corpor Technol       Date:  2007-12

Review 5.  Platelet-activating factor and polyunsaturated fatty acids in cerebral ischemia or convulsions: intracellular PAF-binding sites and activation of a fos/jun/AP-1 transcriptional signaling system.

Authors:  N G Bazan; S P Squinto; P Braquet; T Panetta; V L Marcheselli
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

6.  Properties and regulation of microsomal PAF-synthesizing enzymes in rat brain cortex.

Authors:  E Francescangeli; A Boila; G Goracci
Journal:  Neurochem Res       Date:  2000-05       Impact factor: 3.996

Review 7.  Lipid signaling in neural plasticity, brain repair, and neuroprotection.

Authors:  Nicolas G Bazan
Journal:  Mol Neurobiol       Date:  2005-08       Impact factor: 5.590

8.  Neuroprotection during cardiac surgery: a randomised trial of a platelet activating factor antagonist.

Authors:  D P Taggart; S M Browne; D T Wade; P W Halligan
Journal:  Heart       Date:  2003-08       Impact factor: 5.994

9.  Memory enhancement by intrahippocampal, intraamygdala, or intraentorhinal infusion of platelet-activating factor measured in an inhibitory avoidance task.

Authors:  I Izquierdo; C Fin; P K Schmitz; R C Da Silva; D Jerusalinsky; J A Quillfeldt; M B Ferreira; J H Medina; N G Bazan
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

Review 10.  The pathophysiological role and therapeutic implications of platelet activating factor in diseases of aging.

Authors:  C Kroegel; C Kortsik; N Kroegel; H Matthys
Journal:  Drugs Aging       Date:  1992 Jul-Aug       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.